coronary artery disease treatment

Best use for popular CAD assessment procedure is misunderstood

harminka — Tue, 15 Apr 2008 11:35:53 -0500

What is the best way to determine if you are developing the nation's most deadly condition, coronary artery disease (CAD)?

First clinical trial data of a fully bioabsorbable drug-eluting stent

harminka — Fri, 14 Mar 2008 07:46:09 -0500

Data published today in The Lancet from ABSORB, the world’s first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery disease, demonstrated no stent thrombosis, no clinically driven target lesion revascularizations (re-treatment of a diseased lesion), and a low (3.3 percent) rate of major adverse cardiac events (MACE) in 30 patients out to one year.

Autopsy findings suggest end of decline in coronary disease rates

harminka — Tue, 12 Feb 2008 09:38:02 -0600

Autopsies of individuals in one Minnesota County suggest that the decades-long decline in the rate of coronary artery disease may have ended and possibly reversed after 2000, according to a report in the February 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Urinary biomarkers for coronary disease

harminka — Tue, 12 Feb 2008 09:08:33 -0600

A set of 15 proteins found in urine can distinguish healthy individuals from those who have coronary artery disease (CAD), a new study has found.

Same day coronary angiography, surgery safe for many patients

harminka — Thu, 24 May 2007 11:32:08 -0500

Mayo Clinic researchers discovered it is safe - and much more convenient and less costly -- for many patients to undergo coronary angiography and elective valve surgery on the same day, it is reported in the current issue of Mayo Clinic Proceedings.

Key findings on new-generation stent

harminka — Thu, 10 May 2007 10:48:06 -0500

New data reported at the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI), May 9-12, 2007, in Orlando, FL, will offer clues to the fate of a new-generation drug-eluting stent that is vying for a place in the treatment of coronary artery disease.